The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Reduction in Heart Failure Events by the Addition of a Clinical Pharmacist to the Heart Failure Management Team: Results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study
Abstract
BACKGROUND: The multidisciplinary approach to managing heart failure has been shown to improve outcomes. The role of a clinical pharmacist in treating heart failure has not been evaluated. METHODS: One hundred eighty-one patients with heart failure and left ventricular dysfunction (ejection fraction <45) undergoing evaluation in clinic were randomized to an intervention or a control group. Patients in the intervention group received clinical pharmacist evaluation, which included medication evaluation, therapeutic recommendations to the attending physician, patient education, and follow-up telemonitoring. The control group received usual care. The primary end point was combined all-cause mortality and heart failure clinical events. All clinical events were adjudicated by a blinded end point committee. RESULTS: Baseline characteristics were similar except for slightly higher age in the intervention group. Median follow-up was 6 months. All-cause mortality and heart failure events were significantly lower in the intervention group compared with the control group (4 vs 16; P= .005). In addition, patients in the intervention group received higher angiotensin-converting enzyme inhibitor doses as reflected by the median fraction of target reached (25th and 75th percentiles), 1.0 (0.5 and 1) and 0.5 (0.1875 and 1) in the intervention and control groups, respectively (P<.001). The use of other vasodilators in angiotensin-converting enzyme inhibitor-intolerant patients was higher in the intervention group (75% vs 26%; P= .02). CONCLUSIONS: Outcomes in heart failure can be improved with a clinical pharmacist as a member of the multidisciplinary heart failure team. This observation may be due to higher doses of angiotensin-converting enzyme inhibitors and/or closer follow-up.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rich, M. W., Beckham, V., Wittenberg, C., Leven, C. L., Freedland, K. E., & Carney, R. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511023331806 · Cited by 2,328
The epidemiology of heart failure: The Framingham Study
Ho, K. K. L., Pinsky, J. L., Kannel, W. B., & Levy, D. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90455-a · Cited by 2,247
Does Increased Access to Primary Care Reduce Hospital Readmissions?
Weinberger, M., Oddone, E. Z., & Henderson, W. G. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605303342206 · Cited by 800
Kannel, W. B., & Belanger, A. J. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90225-7 · Cited by 797
Early Readmission of Elderly Patients With Congestive Heart Failure
Vinson, J. M., Rich, M. W., Sperry, J. C., Shah, A. S., & McNamara, T. (1990) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1990.tb03450.x · Cited by 729
Hanlon, J. T., Weinberger, M., Samsa, G. P., Schmader, K. E., Uttech, K. M., Lewis, I. K., Cowper, P. A., Landsman, P. B., Cohen, H. J., & Feussner, J. R. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89519-8 · Cited by 612
Fonarow, G. C., Stevenson, L. W., Walden, J. A., Livingston, N. A., Steimle, A. E., Hamilton, M. A., Moriguchi, J., Tillisch, J. H., & Woo, M. A. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00208-8 · Cited by 541
Miller, N. H., Hill, M., Kottke, T., & Ockene, I. S. (1997) · Circulation · doi:10.1161/01.cir.95.4.1085 · Cited by 493
Precipitating factors leading to decompensation of heart failure. Traits among urban blacks
Ghali, J. K. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.9.2013 · Cited by 412
Rich, M. W. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb02968.x · Cited by 379
Cited by
Weingarten, S. R. (2002) · BMJ · doi:10.1136/bmj.325.7370.925 · Cited by 735
Structured telephone support or telemonitoring programmes for patients with chronic heart failure
Inglis, S. C., Clark, R. A., McAlister, F. A., Ball, J., Lewinter, C., Cullington, D., Stewart, S., & Cleland, J. G. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007228.pub2 · Cited by 614
Pharmacist Intervention to Improve Medication Adherence in Heart Failure: A Randomized Trial
Murray, M. D., Young, J., Hoke, S., Tu, W., Weiner, M., Morrow, D., Stroupe, K. T., Wu, J., Clark, D., Smith, F., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-10-200705150-00005 · Cited by 470
Structured telephone support or non-invasive telemonitoring for patients with heart failure
Inglis, S. C., Clark, R. A., Dierckx, R., Prieto-Merino, D., & Cleland, J. G. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007228.pub3 · Cited by 453
Clinical Pharmacy Services, Pharmacy Staffing, and Hospital Mortality Rates
Bond, C. A., & Raehl, C. L. (2007) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.4.481 · Cited by 428
Metadata
- Authors
- Gattis, W. A., Hasselblad, V., Whellan, D. J., & O'Connor, C. M.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 1999-09-13
- Volume
- 159
- Issue
- 16
- Pages
- 1939
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2171787586
- Cited by
- 462
- References
- 20
- FWCI
- 11.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reduction in Heart Failure Events by the Addition of a Clinical Pharmacist to the Heart Failure Management Team: Results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. https://app.cochat.ai/papers/10.1001/archinte.159.16.1939
- The paper
- Gattis, W. A., Hasselblad, V., Whellan, D. J., & O'Connor, C. M. (1999). Reduction in Heart Failure Events by the Addition of a Clinical Pharmacist to the Heart Failure Management Team: Results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Archives of Internal Medicine. https://doi.org/10.1001/archinte.159.16.1939
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
